Cargando…
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
Patients with relapsed/refractory acute myeloid leukaemia (AML), ineligible for intensive chemotherapy and allogeneic stem cell transplantation, have a dismal prognosis. For such cases, hypomethylating agents are a viable alternative, but with limited success. Combination chemotherapy using a hypome...
Autores principales: | Iluta, Sabina, Pasca, Sergiu, Gafencu, Grigore, Jurj, Ancuta, Terec, Andreea, Teodorescu, Patric, Selicean, Cristina, Jitaru, Ciprian, Preda, Alexandra, Cenariu, Diana, Constantinescu, Catalin, Iordache, Maria, Tigu, Bogdan, Munteanu, Raluca, Feder, Richard, Dima, Delia, Zdrenghea, Mihnea, Gulei, Diana, Ciuleanu, Tudor‐Eliade, Tomuleasa, Ciprian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406486/ https://www.ncbi.nlm.nih.gov/pubmed/34132464 http://dx.doi.org/10.1111/jcmm.16513 |
Ejemplares similares
-
The Predictive Role of Modified Early Warning Score in 174 Hematological Patients at the Point of Transfer to the Intensive Care Unit
por: Constantinescu, Catalin, et al.
Publicado: (2021) -
The Potential Equivalents of TET2 Mutations
por: Pasca, Sergiu, et al.
Publicado: (2021) -
TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020) -
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
por: Munteanu, Raluca, et al.
Publicado: (2023) -
The Influence of Methylating Mutations on Acute Myeloid Leukemia: Preliminary Analysis on 56 Patients
por: Pasca, Sergiu, et al.
Publicado: (2020)